Altimmune (ALT) Current Deferred Revenue (2011 - 2018)
Altimmune (ALT) reported Current Deferred Revenue of $19753.0 for Q3 2018, little changed year-over-year from $19753.0 in Q3 2017, and down 38.76% quarter-over-quarter from $32253.0 in Q2 2018.
Altimmune (ALT) Current Deferred Revenue (2011 - 2018) Analysis & Trends
Altimmune (ALT) has 7 years of Current Deferred Revenue data on file, last reported at $19753.0 in Q3 2018.
- Current Deferred Revenue for Q3 2018 came in at $19753.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2018 was $19753.0 (changed 0.0% YoY), and the FY2017 annual result was $15914.0, down 19.44% from the prior year.
- Current Deferred Revenue slipped to $19753.0 in Q3 2018 per ALT's latest filing, from $32253.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $62261.0 in Q1 2014 and troughed at $15914.0 in Q4 2017.
- A 4-year average of $25785.6 and a median of $19753.0 in 2016 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2014 and 2018: Current Deferred Revenue slumped 92.88% in 2014, then soared 87.38% in 2018.
- A 4-year view of Current Deferred Revenue shows it stood at $62261.0 in 2014, then plunged by 68.27% to $19753.0 in 2016, then slipped by 19.44% to $15914.0 in 2017, then rose by 24.12% to $19753.0 in 2018.
- Business Quant data shows ALT's Current Deferred Revenue at $19753.0 in Q3 2018, $32253.0 in Q2 2018, and $19385.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 19,753.00 |
| Jun 30, 2018 | 32,253.00 |
| Mar 31, 2018 | 19,385.00 |
| Dec 31, 2017 | 15,914.00 |
| Sep 30, 2017 | 19,753.00 |
| Jun 30, 2017 | 17,213.00 |
| Dec 31, 2016 | 19,753.00 |
| Mar 31, 2014 | 62,261.00 |
| Dec 31, 2013 | 341,723.00 |
| Sep 30, 2013 | 471,816.00 |
| Jun 30, 2013 | 508,175.00 |
| Mar 31, 2013 | 874,404.00 |
| Dec 31, 2012 | 1.38 Mn |
| Dec 31, 2011 | 514,312.00 |